Cargando…
Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
INTRODUCTION: Prostate adenocarcinoma (PRAD) is a highly aggressive malignancy with high mortality and poor prognosis, and its potential mechanism remains unclear. Our study aimed to identify novel markers for the prognosis of PRAD using bioinformatics technology. METHODS: The GSE32571 dataset was d...
Autores principales: | Qiao, Shaoyi, Zhang, Wuhe, Su, Yansheng, Jiang, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795034/ https://www.ncbi.nlm.nih.gov/pubmed/36591519 http://dx.doi.org/10.3389/fonc.2022.1037535 |
Ejemplares similares
-
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2016) -
Malignancy and IFITM3: Friend or Foe?
por: Rajapaksa, Ushani S., et al.
Publicado: (2020) -
The prognostic value and immunological role of angiogenesis-related patterns in colon adenocarcinoma
por: Sun, Weijie, et al.
Publicado: (2022) -
Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component
por: Zhang, Shirong, et al.
Publicado: (2021) -
Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis
por: Du, Qingwu, et al.
Publicado: (2023)